CG Oncology, Inc. portfolio
CGONUnited States
Every trademark CG Oncology, Inc. holds, newest filings first. The portfolio has 8 marks.
Search this portfolio
- Trademarks on file
- 8
- Active
- 5
- Owner names grouped
- 1
Portfolio
All trademarks
50 marks per page, newest filing date first. Pick an office to narrow the list.
| Mark | Status | Office | Classes | Filed |
|---|---|---|---|---|
| CGTRUACCESS | examining | USPTO | 9, 35, 36, 42, 44 | 2026-04-20 |
| TRUVESIC | abandoned | USPTO | 42 | 2024-12-04 |
| TRUVESIC | abandoned | USPTO | 5 | 2024-12-04 |
| ONCOLYTIC IMMUNOTHERAPY | abandoned | USPTO | 5, 42 | 2024-03-15 |
| ARAMIRA | allowed | USPTO | 5 | 2023-05-16 |
| TRUVESIC | allowed | USPTO | 5 | 2023-05-16 |
| TRUVESIC | allowed | USPTO | 42 | 2023-05-16 |
| ARAMIRA | allowed | USPTO | 42 | 2023-05-16 |
API
Get this data via the API
Everything on this page comes from the Signa API. Pull CG Oncology, Inc.'s full portfolio into your own product.
GET/v1/entities/{id}/trademarksEvery trademark in the portfolio, filterable by office and class
GET/v1/entities/{id}/analyticsPortfolio totals, disputes and ownership changes
GET/v1/entities/{id}Company record, ticker, LEI and owner names
GET /v1/entities/{id}/trademarks
ID=ent_019eb70f-20f0-736a-805e-dea9ff413d49
curl https://api.signa.so/v1/entities/$ID/trademarks \
-H "Authorization: Bearer $SIGNA_API_KEY"Response
{
"object": "list",
"data": [
{
"id": "tm_019db7f0-1c5c-710f-8929-2a2da1ce358a",
"mark_text": "CGTRUACCESS",
"office_code": "US",
"status": {
"stage": "examining"
},
"filing_date": "2026-04-20"
},
{
"id": "tm_019d2a28-6bbd-7378-8611-74ee6a28bf22",
"mark_text": "TRUVESIC",
"office_code": "US",
"status": {
"stage": "abandoned"
},
"filing_date": "2024-12-04"
}
],
"has_more": false
}